The demand for at-home patient monitoring and greater personal ownership of healthcare continues to grow, as do the opportunities for emerging players in this space.
PI’s Digital team picked up a prestigious Good Design Award Winner Accolade in the Digital Design category at the 2022 Australian Good Design Awards, for its NeoSync: Transforming Point-of-Care Testing connectivity solution.
Until now, many device vendors have had limited, if any, remote visibility into their products.
When developing connectivity for your point-of-care diagnostic product, there are two main routes – build or buy. How do you know what’s right for you?
Planet Innovation is taking another step in providing a safe working environment for on-site staff by introducing voluntary COVID-19 rapid antigen testing at its Australian facility.
As demand for diagnostic and point-of-care (POC) testing grows, new products are coming to life faster than ever. Ben Druce, VP Strategic Design, shares insights from an expert panel discussion he hosted at the MD&M and BIOMEDigital event.
Experts from Truvian, Blue Ox Healthcare Partners, the University of Chicago and PI discuss the potential impact of real-time point-of-care blood testing.
With the COVID-19 pandemic shining a light on the benefits of telehealth, there has never been a better time to be in remote patient monitoring (RPM). But if you’re going to be successful, you need to win over your two main users: patients and clinicians.
A roundup of the latest news and opinions from PI.
Planet Innovation and Lumos Diagnostics have won two awards at the 2020 Good Design Awards, including a Good Design Award Gold accolade for Lumos’s Leelu Reader.
PI has partnered with Truvian, a healthcare company at the intersection of diagnostics and consumer technology, to develop a new point-of-care blood testing device to make routine health tests more convenient, affordable and actionable for consumers.
We are seeking GPs and other healthcare professionals in Victoria, Australia to pilot a new TGA-approved point-of-care test to help differentiate patients with viral from bacterial acute respiratory tract infections.
Lumos Diagnostics and RPS Diagnostics have merged to create a full-service point-of-care diagnostic development company and support the international commercialization of FebriDx.
Lumos Diagnostics is expanding its global footprint after agreeing an ongoing manufacturing deal for a customized lateral flow reader with a California-based life sciences company.
Lumos Diagnostics develops custom products for its partners using a unique combination of integrated assay and engineering capability paired with its proven reader optical technologies.
Planet Innovation’s PoC (Point-of-Care) diagnostic platform, Nplex, will benefit from further investment to develop a cloud-connected medical counter-measures device, for the rapid detection of infectious diseases.
Diagnostics
Life Sciences
Medical Devices
Internet of Things